2025 Agenda
Monday, October 13
Time
Event
8:00 am – Lobby Level
Registration Opens
9:45 am – 2nd Floor
Welcome Remarks
- Sara Jane Demy, Founder & CEO, Demy-Colton
10:00 am – 2nd Floor
Big Think Fireside Chat
Biopharma: What the Future Looks Like
- James Flynn, Managing Partner, Deerfield
Interviewed by:
- Sara Jane Demy, Founder & CEO, Demy-Colton
11:00 am – Lobby Level
One-to-One Meetings
11:00 am – 2nd Floor
Spotlight Panel 1A
Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics
11:00 am – 12th Floor
Spotlight Panel 1B
Rewiring Minds: Breakthroughs in Brain & CNS Health
Moderator:
- Walter Greenleaf, Neuroscientist & Product Developer, Stanford University
12:00 pm – 2nd Floor & Lobby Level
Lunch
1:10 pm – 2nd Floor
“Big Think" Plenary Session
Regenerative Medicine: The Future of Healing
2:00 pm – Lobby Level
One-to-One Meetings
2:00 pm – 2nd Floor
Spotlight Panel 2A
Genomic Alchemy: Redefining Medicine, One Cell at a Time
2:00 pm – 12th Floor
Spotlight Panel 2B
Where Code Meets Cells: Forging the TechBio Future
3:10 pm – 2nd Floor
Spotlight Panel 3A
Immunity Unleashed: Next-Gen Therapies & Immune Engineering
3:10 pm – 12th Floor
Spotlight Panel 3B
Healthspan Horizons: Advancing Longevity Therapeutics
4:15 pm – 2nd Floor
End of Day “Big Think" Plenary Session
The Great Biopharma Reset: Will Today’s Challenging Environment Result in a more Resilient Sector?
Moderator:
- Dennis Purcell, Founder & Senior Advisor, Aisling Capital
Panel:
- Jo Natauri, Founder & Managing Partner, Invidia Capital Management
- Umer Raffat, Equity Research, Evercore ISI
- Philip Ross, Vice Chairman, Global Healthcare Investment Banking, Jefferies LLC
- Eric Schmidt, Biotechnology Analyst, Cantor Fitzgerald
5:00 pm
Networking Reception